Следене
Fuat Karakuş
Fuat Karakuş
Потвърден имейл адрес: yyu.edu.tr - Начална страница
Заглавие
Позовавания
Позовавания
Година
Bioactivation of clozapine by mitochondria of the murine heart: Possible cause of cardiotoxicity
E Arzuk, F Karakuş, H Orhan
Toxicology 447, 152628, 2021
272021
Inhibition of cell proliferation, migration and colony formation of LS174T Cells by carbonic anhydrase inhibitor
F Karakuş, E Eyol, K Yılmaz, S Ünüvar
African health sciences 18 (4), 1303-1310, 2018
192018
Design, synthesis, and antiproliferative activities of novel thiazolyl-pyrazole hybrid derivatives
B Kuzu, A Ergüç, F Karakuş, E Arzuk
Medicinal Chemistry Research 32 (8), 1690-1700, 2023
122023
Mitochondrial Biotransformation of Drugs and Other Xenobiotics
H Orhan, F Karakuş, A Ergüç
Current Drug Metabolism 22 (8), 657-669, 2021
92021
Synergistic Anti-proliferative Effects of Cucurbitacin I and Irinotecan on Human Colorectal Cancer Cell Lines
E Eyol, Z Tanrıverdi, F Karakuş, K Yılmaz, S Ünüvar
Journal of Clinical & Experimental Pharmacology 6 (5), 2016
92016
Cytotoxic Effects of Cucurbitacin I and Ecballium elaterium on Breast Cancer Cells
K Yilmaz, F Karakus, E Eyol, E Tosun, I Yilmaz, S Unuvar
Natural Product Communications 13 (11), 1445-1448, 2018
72018
The relationship between neopterin and hepatitis B surface antigen positivity
S Ünüvar, H Aslanhan, Z Tanrıverdi, F Karakuş
Pteridines 29 (1), 1-5, 2018
72018
Role of oxidative stress and reactive metabolites in cytotoxicity & mitotoxicity of clozapine, diclofenac and nifedipine in CHO-K1 cells in vitro
A Ergüç, F Karakuş, E Arzuk, N Mutlu, H Orhan
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023
62023
Combination of 2 bioactive compounds for treatment of breast cancer: triterpenoid cucurbitacin I and phenolic CAPE
F Karakuş, K Yılmaz, E Eyol, S Ünüvar
Natural Product Communications 14 (6), 1934578X19857492, 2019
62019
Novel Pyrazole Derivatives Bearing Carbonitrile and Substituted Thiazole Moiety for Selective COX‐2 Inhibition
E Arzuk, F Karakuş, A Ergüç, B Kuzu
ChemistrySelect 9 (1), e202304783, 2024
42024
Effect of the Achillea wilhelmsii extract intake upon blood lipid profile, haematologic and immunologic parameters in the rat
F Suzergoz, S Cinar, R Oktay, F Karakus, AO Gurol
Food and Agricultural Immunology 26 (1), 46-59, 2015
42015
Natural Compounds Targeting VEGFRs in Kidney Cancer: An In silico Prediction
B Kuzu, F Karakuş
Journal of the Institute of Science and Technology 12 (3), 1711-1722, 2022
32022
Possible Cardioprotective Mechanism of Action of Dexrazoxane, and Probable Human Topoisomerase IIβ Inhibitors: An In Silico Analysis
F Karakuş, B Kuzu
Journal of Faculty of Pharmacy of Ankara University 46 (2), 474-486, 2022
32022
Potential inhibitors of extra-synaptic NMDAR/TRPM4 interaction: Screening, molecular docking, and structure-activity analysis
E Deniz, F Karakuş, B Kuzu
Computational Toxicology 27, 100279, 2023
22023
Mitochondrial toxicity of selected natural compounds: in vitro assessment and in silico molecular docking and dynamics simulation
A Ergüç, G Albayrak, MT Muhammed, F Karakuş, E Arzuk
Drug and Chemical Toxicology 48 (1), 199-209, 2025
12025
Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction
F Karakuş, B Kuzu, S Köstekci, Y Tülüce
Current Computer-Aided Drug Design 21 (3), 348-361, 2025
12025
Predicting the molecular mechanisms of cardiovascular toxicity induced by per-and polyfluoroalkyl substances: an In Silico network toxicology perspective
F Karakuş, B Kuzu
Toxicology Research 13 (6), 1-8, 2024
12024
Screening and toxicity evaluation of natural compounds as adenosine 2a and 2b receptor ligands: insights from molecular docking, dynamics, and ADMET analysis
F Karakuş, MA Alagöz, B Kuzu
Drug and Chemical Toxicology, 1-10, 2024
12024
In silico drug repurposing as inhibitors against GSK-3β
E Deniz, F Karakuş, B Kuzu
Hacettepe University Journal of the Faculty of Pharmacy, 11-16, 2023
12023
Toxicology of Herbal Medicines
H Orhan, E Arzuk, F Karakuş, A Ergüç
Toxicology for the Health and Pharmaceutical Sciences, 189-220, 2022
12022
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20